Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overexpression of PFKFB3 promotes cell glycolysis and proliferation in renal cell carcinoma
Jun Li, Shiqiang Zhang, Dingzhun Liao, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 19

Showing 19 citing articles:

Targeting Glucose Metabolism Enzymes in Cancer Treatment: Current and Emerging Strategies
Yi Zhang, Qiong Li, Zhao Huang, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4568-4568
Open Access | Times Cited: 80
Targeting glycolysis: exploring a new frontier in glioblastoma therapy
Lu Yang, Sijia Li, Lei Yu, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 2
Hypoxia-Induced Reactive Oxygen Species: Their Role in Cancer Resistance and Emerging Therapies to Overcome It
Eleicy Nathaly Mendoza, Maria Rosa Ciriolo, Fabio Ciccarone
Antioxidants (2025) Vol. 14, Iss. 1, pp. 94-94
Open Access | Times Cited: 2
The regulatory roles and clinical significance of glycolysis in tumor
Qiqi Qiao, Shunfeng Hu, Xin Wang
Cancer Communications (2024) Vol. 44, Iss. 7, pp. 761-786
Open Access | Times Cited: 11
The interplay of p38 MAPK signaling and mitochondrial metabolism, a dynamic target in cancer and pathological contexts
Nadin H. Sarg, Dana M. Zaher, Nour N. Abu Jayab, et al.
Biochemical Pharmacology (2024) Vol. 225, pp. 116307-116307
Closed Access | Times Cited: 9
Molecular mechanisms underlying the role of hypoxia-inducible factor-1 α in metabolic reprogramming in renal fibrosis
Xuejiao Wei, Yue Hou, Mengtuan Long, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 26
TRIB3 promotes the progression of renal cell carcinoma by upregulating the lipid droplet-associated protein PLIN2
Jun Li, Qian Zhang, Yupeng Guan, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 4
USP3 promotes clear cell renal cell carcinoma progression by stabilizing MYC and enhancing glycolysis
Zhiliang Xiao, Yuan Wang, Deng Pan, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2025), pp. 130801-130801
Closed Access
Mitigating renal dysfunction in liver cirrhosis: Therapeutic role of ferrous sulphate, folic acid and its co-administration
Debabrata Dash, Rishu Kumar, Raj Kumar Koiri
Toxicology Reports (2025), pp. 102026-102026
Open Access
HOXD9 contributes to the Warburg effect and tumor metastasis in non-small cell lung cancer via transcriptional activation of PFKFB3
Ke Wan, Jun Shao, Xi Liu, et al.
Experimental Cell Research (2023) Vol. 427, Iss. 1, pp. 113583-113583
Closed Access | Times Cited: 7
SPTBN1 abrogates renal clear cell carcinoma progression via glycolysis reprogramming in a GPT2-dependent manner
Jiajin Wu, Chenkui Miao, Yuhao Wang, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 6
Glycolysis as key regulatory step in FSH-induced rat Sertoli cell proliferation: Role of the mTORC1 pathway
Cecilia Lucía Centola, Marina Ercilia Dasso, J. Soria, et al.
Biochimie (2023) Vol. 214, pp. 145-156
Closed Access | Times Cited: 3
Lipid metabolism-related gene expression in the immune microenvironment predicts prognostic outcomes in renal cell carcinoma
Qian Zhang, Bing-Biao Lin, Huikun Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Comparative clinical significance and biological roles of PFKFB family members in oral squamous cell carcinoma
Kai‐Fang Hu, Chih‐Wen Shu, Cheng‐Hsin Lee, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Mechanistic studies of PFKFB2 reveals a novel inhibitor of its kinase activity
Craig A. Eyster, Satoshi Matsuzaki, Atul Pranay, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Genomic Deletion of PFKFB3 Decreases In Vivo Tumorigenesis
Yoannis Imbert-Fernandez, Simone Chang, Lilibeth Lanceta, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2330-2330
Open Access
Emerging roles of the chromatin remodeler MORC2 in cancer metabolism
Bibhukalyan Mohapatra, Suresh B. Pakala
Medical Oncology (2024) Vol. 41, Iss. 9
Closed Access
Transcriptome Analysis Reveals the Early Development in Subcutaneous Adipose Tissue of Laiwu Piglets
Liwen Bian, Zhaoyang Di, Mengya Xu, et al.
Animals (2024) Vol. 14, Iss. 20, pp. 2955-2955
Open Access
Systematic pan-cancer analysis identifies 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) as a biomarker of tumor invasion and metastasis, immunity, and prognosis
Dandan Liu, Yingying Liu, Chaoyang Zhang, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top